Sodium–Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction

Sodium–Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction

Sodium–glucose cotransporter-2 inhibitors (SGLT2i) are a specific class of drugs originally developed for treating type 2 diabetes mellitus. Subsequently, studies demonstrated that their action was not limited to glycemic control but could also have positive effects on other specific outcomes, parti...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicia I. Profili, Roberto Castelli, Roberto Manetti, Marta C. Sircana, Michela Pagni, Gemma Lisa Sechi, Antonio Gidaro, Costantino Cossu, Francesco Bella, Alessandro P. Delitala
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Biomedicines
Subjects:
SGLT2i
sodium–glucose cotransporter-2 inhibitors
acute myocardial infarction
acute heart failure
diabetes
cardiovascular disease
Online Access:https://www.mdpi.com/2227-9059/13/3/720
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2227-9059/13/3/720

Similar Items